Wexford Capital’s Sanofi SNY Stock Holding History

Wexford Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-16,000	Closed	-$772K	–	283
2024 Q4	$772K	Buy	16,000 +1,000	+7%	+$50.8K	0.12%	80
2024 Q3	$864K	Buy	+15,000	New	+$810K	0.21%	75

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wexford Capital's SNY Position: Q1 2025 in Review

Wexford Capital sold out of Sanofi (SNY) in Q1 2025, closing a stake of 16,000 shares — an estimated $772K sold.

Wexford Capital first reported a position in SNY in Q3 2024 and held it in 2 quarters. The position peaked at $864K in Q3 2024. 771 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

Wexford Capital reported no remaining Sanofi position as of Q1 2025 after selling out during the quarter.
Wexford Capital sold 16,000 Sanofi shares in Q1 2025, an estimated $772K.
Wexford Capital first reported a position in Sanofi in Q3 2024 and held it in 2 quarters.
Wexford Capital's Sanofi position peaked at $864K in Q3 2024.
771 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Wexford Capital's 13F filing for Q1 2025, filed 15 May 2025.